KEGG ORTHOLOGY: K05469

ORTHOLOGY: K05469

Entry

K05469                      KO

Symbol

TNFSF4, OX40L, CD252

Name

tumor necrosis factor ligand superfamily member 4

Pathway

map04060

Cytokine-cytokine receptor interaction

Disease

H01730

Myocardial infarction

Brite

KEGG Orthology (KO) [BR:ko00001]
09130 Environmental Information Processing
  09133 Signaling molecules and interaction
   04060 Cytokine-cytokine receptor interaction
    K05469  TNFSF4, OX40L, CD252; tumor necrosis factor ligand superfamily member 4
09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04052 Cytokines and neuropeptides
    K05469  TNFSF4, OX40L, CD252; tumor necrosis factor ligand superfamily member 4
   04090 CD molecules
    K05469  TNFSF4, OX40L, CD252; tumor necrosis factor ligand superfamily member 4
Cytokines and neuropeptides [BR:ko04052]
Cytokines
  Tumor necrosis fators
   K05469  TNFSF4, OX40L, CD252; tumor necrosis factor ligand superfamily member 4
CD molecules [BR:ko04090]
Proteins
  K05469  CD252, TNFSF4; tumor necrosis factor (ligand) superfamily, member 4

Other DBs

GO:

0005164

Genes

HSA:	7292(TNFSF4)

PTR:	469586(TNFSF4)

PPS:	100971741(TNFSF4)

GGO:	101139622(TNFSF4)

PON:	100457749(TNFSF4)

NLE:	100599087(TNFSF4)

HMH:	116473226(TNFSF4)

MCC:	706255(TNFSF4)

MCF:	102141877(TNFSF4)

MTHB:

126941413

MNI:	105484436(TNFSF4)

CSAB:

103230569(TNFSF4)

CATY:

105597561(TNFSF4)

PANU:

101003106(TNFSF4)

TGE:	112636221(TNFSF4)

MLEU:

105554123(TNFSF4)

RRO:	104665511(TNFSF4)

RBB:	108526262(TNFSF4)

TFN:	117075271(TNFSF4)

PTEH:

111539345(TNFSF4)

CANG:

105526357(TNFSF4)

CJC:	100394933(TNFSF4)

SBQ:	101034704(TNFSF4)

CIMI:

108305378(TNFSF4)

CSYR:

103258432(TNFSF4)

MMUR:

105871664(TNFSF4)

LCAT:

123634829(TNFSF4)

PCOQ:

105821122(TNFSF4)

OGA:	100946600(TNFSF4)

MMU:	22164(Tnfsf4)

MCAL:

110304775(Tnfsf4)

MPAH:

110322632(Tnfsf4)

RNO:	89814(Tnfsf4)

MCOC:

116070781(Tnfsf4)

ANU:	117716298(Tnfsf4)

CGE:	100773775(Tnfsf4)

MAUA:

101843135(Tnfsf4)

PROB:

127223266(Tnfsf4)

PLEU:

114690028(Tnfsf4)

MORG:

121454893(Tnfsf4)

MFOT:

126493632

AAMP:

119827013(Tnfsf4)

NGI:	103738077(Tnfsf4)

HGL:	101698261(Tnfsf4)

CPOC:

100732129(Tnfsf4)

CCAN:

109679323(Tnfsf4)

DORD:

105985150(Tnfsf4)

PLOP:

125360139(Tnfsf4)

NCAR:

124961840

MMMA:

107147371(Tnfsf4)

OCU:	100008595(TNFSF4)

OPI:	101528010(TNFSF4)

TUP:	102500769(TNFSF4)

GVR:	103608552(TNFSF4)

CFA:	100855878(TNFSF4)

CLUD:

112648235(TNFSF4)

VVP:	112921735(TNFSF4)

VLG:	121487701(TNFSF4)

NPO:	129505779(TNFSF4)

AML:	100468487(TNFSF4)

UMR:	103668124(TNFSF4)

UAH:	113262823(TNFSF4)

UAR:	123801402(TNFSF4)

ELK:

111150852

LLV:

125086080

MPUF:

101688084(TNFSF4)

MNP:	132026048(TNFSF4)

MLK:	131814582(TNFSF4)

NVS:	122918499(TNFSF4)

ORO:	101378376(TNFSF4)

EJU:	114223931(TNFSF4)

ZCA:	113933506(TNFSF4)

MLX:	118014467(TNFSF4)

NSU:	110574009(TNFSF4)

LWW:	102743595(TNFSF4)

FCA:	790947(TNFSF4)

PYU:	121015023(TNFSF4)

PCOO:

112863206(TNFSF4)

PBG:	122475839(TNFSF4)

PVIV:

125155250(TNFSF4)

LRUF:

124510457

PTG:	102959104(TNFSF4)

PPAD:

109252538(TNFSF4)

PUC:

125925161

AJU:

106979843

HHV:	120226683(TNFSF4)

BTA:	539800(TNFSF4)

BOM:	102282126(TNFSF4)

BIU:	109570755(TNFSF4)

BBUB:

102403474(TNFSF4)

BBIS:

104995823(TNFSF4)

CHX:	102179308(TNFSF4)

OAS:	101109029(TNFSF4)

BTAX:

128061854(TNFSF4)

ODA:	120880239(TNFSF4)

CCAD:

122452155(TNFSF4)

MBEZ:

129551557(TNFSF4)

SSC:	574053(TNFSF4)

CFR:	102504347(TNFSF4)

CBAI:

105070271(TNFSF4)

CDK:	105092773(TNFSF4)

VPC:	102543152(TNFSF4)

BACU:

103000388(TNFSF4)

BMUS:

118882356(TNFSF4)

LVE:	103072521(TNFSF4)

OOR:	101272939(TNFSF4)

DLE:	111170263(TNFSF4)

PCAD:

102975779(TNFSF4)

PSIU:

116738982(TNFSF4)

NASI:

112391616(TNFSF4)

ECB:	100060605(TNFSF4)

EPZ:	103544216(TNFSF4)

EAI:	106838671(TNFSF4)

MYB:	102259406(TNFSF4)

MYD:	102769526(TNFSF4)

MMYO:

118673218(TNFSF4)

MLF:	102440688(TNFSF4)

PKL:	118721452(TNFSF4)

EFUS:

103290093(TNFSF4)

MNA:	107543743(TNFSF4)

DRO:	112320843(TNFSF4)

SHON:

118979184(TNFSF4)

AJM:	119065392(TNFSF4)

PDIC:

114512140(TNFSF4)

PHAS:

123818500(TNFSF4)

MMF:	118637006(TNFSF4)

PPAM:

129081936(TNFSF4)

HAI:	109384958(TNFSF4)

RFQ:	117014869(TNFSF4)

PALE:

102882703(TNFSF4)

PGIG:

120617662(TNFSF4)

PVP:	105299794(TNFSF4)

RAY:	107512053(TNFSF4)

MJV:	108383807(TNFSF4)

TOD:	119241283(TNFSF4)

SARA:

101546569(TNFSF4)

SETR:

126013526(TNFSF4)

LAV:	100669282(TNFSF4)

TMU:

101352610

ETF:	101642049(TNFSF4)

DNM:	101414757(TNFSF4)

MDO:	103093278(TNFSF4)

GAS:	123245897(TNFSF4)

SHR:	111720388(TNFSF4)

PCW:	110196983(TNFSF4)

OAA:	100084720(TNFSF4)

GGA:	424384(TNFSF4)

MGP:	104912333(TNFSF4)

CJO:	107317184(TNFSF4)

TPAI:

128072665(TNFSF4)

LMUT:

125693087(TNFSF4)

APLA:

113844283(TNFSF4)

ACYG:

106041572(TNFSF4)

CATA:

118243355(TNFSF4)

TGU:	115496298(TNFSF4)

PMOA:

120497590

OTC:	121344328(TNFSF4)

PRUF:

121359745(TNFSF4)

GFR:	102045252(TNFSF4)

FAB:	107603774(TNFSF4)

PHI:

106628454

PMAJ:

107208040(TNFSF4)

CCW:	109145969(TNFSF4)

CBRC:

108445550(TNFSF4)

ZAB:	106629668(TNFSF4)

SVG:	106852214(TNFSF4)

MMEA:

130577435

HRT:	120756603(TNFSF4)

FPG:	106112729(TNFSF4)

FCH:	106630936(TNFSF4)

CLV:

106145770

AFOR:

109279298(TNFSF4)

ACHC:

115349686(TNFSF4)

SHAB:

115611219(TNFSF4)

ACAR:

114818732(TNFSF4)

AAM:	106499691(TNFSF4)

AROW:

112977172(TNFSF4)

NPD:	112951188(TNFSF4)

DNE:	112997351(TNFSF4)

CMY:	102930789(TNFSF4)

CCAY:

125641206(TNFSF4)

DCC:	119859621(TNFSF4)

CPIC:

101930764(TNFSF4)

TST:	117881574(TNFSF4)

MRV:	120369692(TNFSF4)

ACS:

SUND:

PMUA:

ZVI:

HCG:

Reference

PMID:1996093

Authors

Miura S, Ohtani K, Numata N, Niki M, Ohbo K, Ina Y, Gojobori T, Tanaka Y, Tozawa H, Nakamura M, et al.

Title

Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax.

Journal

Mol Cell Biol 11:1313-25 (1991)
DOI:10.1128/MCB.11.3.1313

Sequence

[hsa:7292]

LinkDB

DBGET integrated database retrieval system